Baker Bros. Advisors LP 2seventy Bio, Inc. Transaction History

Baker Bros. Advisors LP

  • $9.86 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$9.21 - $14.98 $4 Million - $6.51 Million
434,782 Added 21.08%
2,497,526 $25.5 Million
Q1 2022

May 16, 2022
BUY
$11.67 - $26.72 $14.3 Million - $32.9 Million
1,229,508 Added 147.56%
2,062,744 $35.2 Million
Q4 2021

Feb 14, 2022
BUY
$13.77 - $42.56 $11.5 Million - $35.5 Million
833,236 New
833,236 $21.4 Million

Others Institutions Holding TSVT

# of Institutions
19
Shares Held
5.01M
Call Options Held
0
Put Options Held
0
View Full List

About 2seventy bio, Inc.

TSVT Quotes by TradingView
  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $189M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email